Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals
Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, e...
Gespeichert in:
Veröffentlicht in: | Journal of antimicrobial chemotherapy 2003-09, Vol.52 (3), p.507-510 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 510 |
---|---|
container_issue | 3 |
container_start_page | 507 |
container_title | Journal of antimicrobial chemotherapy |
container_volume | 52 |
creator | Randall, L. P. Ridley, A. M. Cooles, S. W. Sharma, M. Sayers, A. R. Pumbwe, L. Newell, D. G. Piddock, L. J. V. Woodward, M. J. |
description | Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, erythromycin, kanamycin, tetracycline, cetrimide, triclosan, acridine orange, paraquat and ethidium bromide were determined. Resistance to organic solvents and the effect of salicylate (known inducer of the marRAB operon in Escherichia coli and Salmonella) were also examined. Results: Two C. coli and 13 C. jejuni isolates, mainly from pigs or poultry, were resistant to three or more antibiotics and 12 of these strains had reduced susceptibility to acridine orange and/or ethidium bromide. Strains (n = 20) that were less susceptible to acridine orange, ethidium bromide and triclosan were significantly more resistant (P < 0.05) to ampicillin, chloramphenicol, ciprofloxacin, erythromycin, nalidixic acid and tetracycline, with two- to four-fold increases in MIC values compared with strains (n = 20) most susceptible to acridine orange, ethidium bromide and triclosan. Growth of strains with 1 mM salicylate caused a small (up to two-fold) but statistically significant (P ≤ 0.005) increase in the MICs of chloramphenicol, ciprofloxacin, erythromycin and tetracycline. Conclusions: These data indicate that multiple antibiotic resistant (MAR)-like Campylobacter strains occur and it may be postulated that these may overexpress cmeABC or another efflux system. |
doi_str_mv | 10.1093/jac/dkg379 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19260944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>431327361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-801ae7c6a6f7bd0b62ed3b474bb7ebaeb814c299eb606d6c38a8afede26f93e13</originalsourceid><addsrcrecordid>eNpdkU1r3DAQhkVpaDbbXvoDiii0h4ITyZIl6xg2TbcQ-gEtlF6EJI9TbWTLleyQ_Psq7NJADsMc5uFl5hmEXlNySoliZzvjzrqbaybVM7SiXJCqJoo-RyvCSFNJ3rBjdJLzjhAiGtG-QMe0VlTWnK7Q9bcEtybA6ADHHg9LmP0UAJtx9tbH2TucIPs8mwfCj5hzhjdmmO5DtMbNkHCeplPscwxmhg73KQ74zzKYMZeQrpQfTMgv0VFfGrw69DX6efnxx2ZbXX399HlzflU5TtRctYQakE4Y0UvbEStq6JjlklsrwRqwLeWuVgqsIKITjrWmNT10UIteMaBsjd7vc6cU_y6QZz347CAEM0JcsqaqFkSVI9bo7RNwF5c0lt10TaUQpOgp0Ic95FLMOUGvp1TOSfeaEv3gXhf3eu--wG8OiYsdoHtED7IL8O4AmOxM6FNx6vMj15SvcdoWrtpzRTvc_Z-bdKOFZLLR21-_9bb9ri4uKNVf2D9v4p02</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217660241</pqid></control><display><type>article</type><title>Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Randall, L. P. ; Ridley, A. M. ; Cooles, S. W. ; Sharma, M. ; Sayers, A. R. ; Pumbwe, L. ; Newell, D. G. ; Piddock, L. J. V. ; Woodward, M. J.</creator><creatorcontrib>Randall, L. P. ; Ridley, A. M. ; Cooles, S. W. ; Sharma, M. ; Sayers, A. R. ; Pumbwe, L. ; Newell, D. G. ; Piddock, L. J. V. ; Woodward, M. J.</creatorcontrib><description>Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, erythromycin, kanamycin, tetracycline, cetrimide, triclosan, acridine orange, paraquat and ethidium bromide were determined. Resistance to organic solvents and the effect of salicylate (known inducer of the marRAB operon in Escherichia coli and Salmonella) were also examined. Results: Two C. coli and 13 C. jejuni isolates, mainly from pigs or poultry, were resistant to three or more antibiotics and 12 of these strains had reduced susceptibility to acridine orange and/or ethidium bromide. Strains (n = 20) that were less susceptible to acridine orange, ethidium bromide and triclosan were significantly more resistant (P < 0.05) to ampicillin, chloramphenicol, ciprofloxacin, erythromycin, nalidixic acid and tetracycline, with two- to four-fold increases in MIC values compared with strains (n = 20) most susceptible to acridine orange, ethidium bromide and triclosan. Growth of strains with 1 mM salicylate caused a small (up to two-fold) but statistically significant (P ≤ 0.005) increase in the MICs of chloramphenicol, ciprofloxacin, erythromycin and tetracycline. Conclusions: These data indicate that multiple antibiotic resistant (MAR)-like Campylobacter strains occur and it may be postulated that these may overexpress cmeABC or another efflux system.</description><identifier>ISSN: 0305-7453</identifier><identifier>ISSN: 1460-2091</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkg379</identifier><identifier>PMID: 12917241</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; beta-Lactamases - metabolism ; Biological and medical sciences ; Campylobacter - drug effects ; Campylobacter - genetics ; Campylobacter - metabolism ; Campylobacter coli ; Campylobacter Infections - microbiology ; Campylobacter jejuni ; cmeABC ; Coloring Agents - pharmacology ; Disinfectants - pharmacology ; Drug Resistance, Multiple, Bacterial ; efflux ; ethidium bromide ; Genes, MDR - genetics ; Herbicides - pharmacology ; Humans ; Medical sciences ; Microbial Sensitivity Tests ; Paraquat - pharmacology ; Pharmacology. Drug treatments ; Phenotype ; salicylate ; Salicylates - pharmacology ; Solvents</subject><ispartof>Journal of antimicrobial chemotherapy, 2003-09, Vol.52 (3), p.507-510</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Sep 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-801ae7c6a6f7bd0b62ed3b474bb7ebaeb814c299eb606d6c38a8afede26f93e13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15091418$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12917241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Randall, L. P.</creatorcontrib><creatorcontrib>Ridley, A. M.</creatorcontrib><creatorcontrib>Cooles, S. W.</creatorcontrib><creatorcontrib>Sharma, M.</creatorcontrib><creatorcontrib>Sayers, A. R.</creatorcontrib><creatorcontrib>Pumbwe, L.</creatorcontrib><creatorcontrib>Newell, D. G.</creatorcontrib><creatorcontrib>Piddock, L. J. V.</creatorcontrib><creatorcontrib>Woodward, M. J.</creatorcontrib><title>Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J. Antimicrob. Chemother</addtitle><description>Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, erythromycin, kanamycin, tetracycline, cetrimide, triclosan, acridine orange, paraquat and ethidium bromide were determined. Resistance to organic solvents and the effect of salicylate (known inducer of the marRAB operon in Escherichia coli and Salmonella) were also examined. Results: Two C. coli and 13 C. jejuni isolates, mainly from pigs or poultry, were resistant to three or more antibiotics and 12 of these strains had reduced susceptibility to acridine orange and/or ethidium bromide. Strains (n = 20) that were less susceptible to acridine orange, ethidium bromide and triclosan were significantly more resistant (P < 0.05) to ampicillin, chloramphenicol, ciprofloxacin, erythromycin, nalidixic acid and tetracycline, with two- to four-fold increases in MIC values compared with strains (n = 20) most susceptible to acridine orange, ethidium bromide and triclosan. Growth of strains with 1 mM salicylate caused a small (up to two-fold) but statistically significant (P ≤ 0.005) increase in the MICs of chloramphenicol, ciprofloxacin, erythromycin and tetracycline. Conclusions: These data indicate that multiple antibiotic resistant (MAR)-like Campylobacter strains occur and it may be postulated that these may overexpress cmeABC or another efflux system.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>beta-Lactamases - metabolism</subject><subject>Biological and medical sciences</subject><subject>Campylobacter - drug effects</subject><subject>Campylobacter - genetics</subject><subject>Campylobacter - metabolism</subject><subject>Campylobacter coli</subject><subject>Campylobacter Infections - microbiology</subject><subject>Campylobacter jejuni</subject><subject>cmeABC</subject><subject>Coloring Agents - pharmacology</subject><subject>Disinfectants - pharmacology</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>efflux</subject><subject>ethidium bromide</subject><subject>Genes, MDR - genetics</subject><subject>Herbicides - pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Paraquat - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>salicylate</subject><subject>Salicylates - pharmacology</subject><subject>Solvents</subject><issn>0305-7453</issn><issn>1460-2091</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1r3DAQhkVpaDbbXvoDiii0h4ITyZIl6xg2TbcQ-gEtlF6EJI9TbWTLleyQ_Psq7NJADsMc5uFl5hmEXlNySoliZzvjzrqbaybVM7SiXJCqJoo-RyvCSFNJ3rBjdJLzjhAiGtG-QMe0VlTWnK7Q9bcEtybA6ADHHg9LmP0UAJtx9tbH2TucIPs8mwfCj5hzhjdmmO5DtMbNkHCeplPscwxmhg73KQ74zzKYMZeQrpQfTMgv0VFfGrw69DX6efnxx2ZbXX399HlzflU5TtRctYQakE4Y0UvbEStq6JjlklsrwRqwLeWuVgqsIKITjrWmNT10UIteMaBsjd7vc6cU_y6QZz347CAEM0JcsqaqFkSVI9bo7RNwF5c0lt10TaUQpOgp0Ic95FLMOUGvp1TOSfeaEv3gXhf3eu--wG8OiYsdoHtED7IL8O4AmOxM6FNx6vMj15SvcdoWrtpzRTvc_Z-bdKOFZLLR21-_9bb9ri4uKNVf2D9v4p02</recordid><startdate>20030901</startdate><enddate>20030901</enddate><creator>Randall, L. P.</creator><creator>Ridley, A. M.</creator><creator>Cooles, S. W.</creator><creator>Sharma, M.</creator><creator>Sayers, A. R.</creator><creator>Pumbwe, L.</creator><creator>Newell, D. G.</creator><creator>Piddock, L. J. V.</creator><creator>Woodward, M. J.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20030901</creationdate><title>Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals</title><author>Randall, L. P. ; Ridley, A. M. ; Cooles, S. W. ; Sharma, M. ; Sayers, A. R. ; Pumbwe, L. ; Newell, D. G. ; Piddock, L. J. V. ; Woodward, M. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-801ae7c6a6f7bd0b62ed3b474bb7ebaeb814c299eb606d6c38a8afede26f93e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>beta-Lactamases - metabolism</topic><topic>Biological and medical sciences</topic><topic>Campylobacter - drug effects</topic><topic>Campylobacter - genetics</topic><topic>Campylobacter - metabolism</topic><topic>Campylobacter coli</topic><topic>Campylobacter Infections - microbiology</topic><topic>Campylobacter jejuni</topic><topic>cmeABC</topic><topic>Coloring Agents - pharmacology</topic><topic>Disinfectants - pharmacology</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>efflux</topic><topic>ethidium bromide</topic><topic>Genes, MDR - genetics</topic><topic>Herbicides - pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Paraquat - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>salicylate</topic><topic>Salicylates - pharmacology</topic><topic>Solvents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Randall, L. P.</creatorcontrib><creatorcontrib>Ridley, A. M.</creatorcontrib><creatorcontrib>Cooles, S. W.</creatorcontrib><creatorcontrib>Sharma, M.</creatorcontrib><creatorcontrib>Sayers, A. R.</creatorcontrib><creatorcontrib>Pumbwe, L.</creatorcontrib><creatorcontrib>Newell, D. G.</creatorcontrib><creatorcontrib>Piddock, L. J. V.</creatorcontrib><creatorcontrib>Woodward, M. J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Randall, L. P.</au><au>Ridley, A. M.</au><au>Cooles, S. W.</au><au>Sharma, M.</au><au>Sayers, A. R.</au><au>Pumbwe, L.</au><au>Newell, D. G.</au><au>Piddock, L. J. V.</au><au>Woodward, M. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J. Antimicrob. Chemother</addtitle><date>2003-09-01</date><risdate>2003</risdate><volume>52</volume><issue>3</issue><spage>507</spage><epage>510</epage><pages>507-510</pages><issn>0305-7453</issn><issn>1460-2091</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, erythromycin, kanamycin, tetracycline, cetrimide, triclosan, acridine orange, paraquat and ethidium bromide were determined. Resistance to organic solvents and the effect of salicylate (known inducer of the marRAB operon in Escherichia coli and Salmonella) were also examined. Results: Two C. coli and 13 C. jejuni isolates, mainly from pigs or poultry, were resistant to three or more antibiotics and 12 of these strains had reduced susceptibility to acridine orange and/or ethidium bromide. Strains (n = 20) that were less susceptible to acridine orange, ethidium bromide and triclosan were significantly more resistant (P < 0.05) to ampicillin, chloramphenicol, ciprofloxacin, erythromycin, nalidixic acid and tetracycline, with two- to four-fold increases in MIC values compared with strains (n = 20) most susceptible to acridine orange, ethidium bromide and triclosan. Growth of strains with 1 mM salicylate caused a small (up to two-fold) but statistically significant (P ≤ 0.005) increase in the MICs of chloramphenicol, ciprofloxacin, erythromycin and tetracycline. Conclusions: These data indicate that multiple antibiotic resistant (MAR)-like Campylobacter strains occur and it may be postulated that these may overexpress cmeABC or another efflux system.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>12917241</pmid><doi>10.1093/jac/dkg379</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-7453 |
ispartof | Journal of antimicrobial chemotherapy, 2003-09, Vol.52 (3), p.507-510 |
issn | 0305-7453 1460-2091 1460-2091 |
language | eng |
recordid | cdi_proquest_miscellaneous_19260944 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry |
subjects | Animals Anti-Bacterial Agents - pharmacology Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents beta-Lactamases - metabolism Biological and medical sciences Campylobacter - drug effects Campylobacter - genetics Campylobacter - metabolism Campylobacter coli Campylobacter Infections - microbiology Campylobacter jejuni cmeABC Coloring Agents - pharmacology Disinfectants - pharmacology Drug Resistance, Multiple, Bacterial efflux ethidium bromide Genes, MDR - genetics Herbicides - pharmacology Humans Medical sciences Microbial Sensitivity Tests Paraquat - pharmacology Pharmacology. Drug treatments Phenotype salicylate Salicylates - pharmacology Solvents |
title | Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A53%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20multiple%20antibiotic%20resistance%20in%20443%20Campylobacter%20spp.%20isolated%20from%20humans%20and%20animals&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Randall,%20L.%20P.&rft.date=2003-09-01&rft.volume=52&rft.issue=3&rft.spage=507&rft.epage=510&rft.pages=507-510&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/dkg379&rft_dat=%3Cproquest_cross%3E431327361%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217660241&rft_id=info:pmid/12917241&rfr_iscdi=true |